BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:7452@myasthenia.org
DTSTART;TZID=America/New_York:20250714T150000
DTEND;TZID=America/New_York:20250714T150000
DTSTAMP:20250702T175925Z
URL:https://myasthenia.org/events/webinar-a-study-to-assess-efficacy-and-s
 afety-of-efgartigimod-ph20-sc-in-adults-with-ocular-myasthenia-gravis-adap
 t-oculus/
SUMMARY:Webinar: A Study to Assess Efficacy and Safety of Efgartigimod PH20
  SC in Adults With Ocular Myasthenia Gravis (ADAPT oculus)
DESCRIPTION:Monday\, July 14\, 2025 3:00 PM Eastern Time / 12:00 PM Pacific
  Time\nPresenter:  Rosa H. Jimenz\, M.D.\, PhD\, MG Indication Lead\, Cli
 nical Development\, argenx\nJoin Dr. Jimenz for a webinar sharing more inf
 ormation about a clinical study open to adults with ocular myasthenia grav
 is. This study is assessing the safety and efficacy of efgartigimod PH20 S
 C (a version of Vyvgart) in treating ocular MG.\n\nCome join us to learn m
 ore and ask your questions about participating in a clinical trial.\n\nThi
 s webinar is sponsored by argenx.\nRegister
CATEGORIES:Events,National Events,Webinars
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
DTSTART:20250309T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR